Reticulated platelets are associated with long-term outcomes of premature coronary artery disease following percutaneous coronary intervention

Experimental and Clinical Cardiology

Volumn 20, Issue 6, 2014, Pages 145-163

  Zhang, Yan ^a   Wang, Cong Xia ^a   Li, Man Xiang ^a   Li, Yong Qin ^a   Wu, Xiao San ^a   Zhang, Chun Yan ^a   Jia, Shan ^a   Zhang, Lin ^a  

^a NONE

Author keywords

Long term outcomes; Premature coronary artery disease; Reticulated platelets

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; ARTICLE; CARDIAC PATIENT; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREMATURE CORONARY ARTERY DISEASE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETICULATED PLATELET; STABLE ANGINA PECTORIS; THROMBOCYTE;

EID: 84903844478     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chen L, Chester M, Kaski JC. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 1995;108:364-369.
2. Matic GB, Chapman ES, Zaiss M, Rothe G, Schmitz G. Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry 1998; 34:229-234.
3. Abe Y, Wada H, Sakakura M, Nishioka J, Tomatsu H, Hamaguchi Y.Usefulness of fully automated measurement of reticulated platelets using whole blood. Clin Appl Thromb Hemost 2005;11:263-270. (Pubitemid 41022855)
4. M.Monteagudo Jiménez, M.J. Amengual Guedán, L. Muñoz Martín, J.A. Soler Campos, I. Roig Martínez, C. Tolosa Vilella. Measurement of reticulated platelets by simple flow cytometry: An indirect thrombocytopoietic marker.European Journal of Internal Medicine, 2006;17:541-544.
5. Lakkis N, Dokainish H, Abuzahra M, Tsyboulev V, Jorgensen J, Audrie PD, Abdus S. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 2004;44:2091-2093. (Pubitemid 39473299)
6. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 2004;126:861-869. (Pubitemid 39273828)
7. Macchi I, Chamlian V, Sadoun A, Le DA, Guilhot J, Guilhot F. Comparison of reticulated platelet count and mean platelet volume determination in the evaluation of bone marrow recovery after aplastic chemotherapy. Eur J Haematol Sep 2002;69:152-157. (Pubitemid 35335152)
8. Robinson MS, MacKie IJ, Machin SJ, Harrison P. Two colour analysis of reticulated platelets. Clin Lab Haematol Aug, 2000;22:211-213.
9. Robinson MSC, Mackie IJ, Khair K, et al. Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labeling of dense granules by fluorescent dyes. Br J Haematol 1998;100:351-357. (Pubitemid 28131070)
10. Jiménez MM, Guedán MJ, Muñoz M, Muñoz Martín JA, Campos SI, Martínez RC, Vilella T. Measurement of reticulated platelets by simple flow cytometry: An indirect thrombocytopoietic marker. European Journal of Internal Medicine 2006;17:541-544.
11. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
12. Guthikonda S, Alviar CL, Vaduganathan M, Arikan M, Tellez A, DeLao T, et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52:743-9.
13. Rinder HM, Munz UJ, Ault KA, Bonan JL, Smith BR. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med Jun 1993;117:606-10. (Pubitemid 23166779)
14. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646.
15. Sandro CG, Marino L, Michel LM. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiology 2011:204-209.
16. Teruhisa F, Takeshi S, Tetsurou T, Fujimoto, Akirou K, Kingo F. A New Approach to detect reticulated platelets stained with Thiazole orange in thrombocytopenic patients. Thrombosis Res 1997; 2000:431-440.
17. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 2003;92:285-293. (Pubitemid 37509996)
18. Fuchs S, Kornowski R, Mehran R, Lansky AJ, Satler LF, Pichard AD, Kent KM, Clark CE, Stone GW, Leon MB. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000;85:1077-1082. (Pubitemid 30214252)
19. Simoons ML, van den Brand M, Lincoff M, Harrington R, van der Wieken R, Vahanian A, Rutsch W, Kootstra J, Boersma E, Califf RM, Topol E. Minimal myocardial damage during coronary intervention is associated with impaired outcome. Eur Heart J 1999;20:1112-1119. (Pubitemid 29348549)